The new year is ringing in with higher drug prices.

新年到了，药品价格也上涨了。

Allergan is reportedly setting the pace with increases of nearly 10 percent on more than two dozen products, according to the Wall Street Journal.

据《华尔街日报》报道，爱力根公司据说主动将20多种产品的价格上调了近10%。

While many of the increases are relatively modest, a few are particularly high, including on some generics, the cheaper alternative to branded accounting for nine out of 10 prescriptions filled in the US.

尽管其中许多增幅相对温和，但也有少数增幅特别大，其中包括一些仿制药。在美国，仿制药是比品牌药更便宜的选择，每10张处方中有9张开的是仿制药。

Still, many price increases exceed inflation.

尽管如此，许多价格的增幅还是超过了通胀。

More than three dozen drugmakers raised the prices on hundreds of medicines in the US on Tuesday, according to an analysis from Rx Savings Solutions, which sells software to help employers and health plans choose the least expensive medicines.

Rx Savings Solutions平台的一份分析报告显示，美国30多家制药商周二上调了数百种药品的价格。Rx Savings Solutions平台销售软件，帮助雇主和医疗计划选择最便宜的药品。

The average increase was 6.3 percent, according to the analysis, including increases on different doses for the same drug.

根据分析，包括同一种药物不同剂量的增幅在内，平均增幅是6.3%。

Allergan confirmed the increases cited in the analysis, saying it raised the price of 51 products — 27 by about 9.5 percent and another 24 by about 4.9 percent.

爱力根公司证实了分析报告中提到的涨价，称该公司将51种产品的价格提高了，其中27种产品的价格提高了约9.5%，另外24种产品的价格提高了约4.9%。

The increases covered more than half of its portfolio, from an extended-release version of its Alzheimer’s drug Namenda to dry-eye treatment Restasis.

其投资组合的一半以上药品都涨价了，从老年痴呆症药物盐酸美金刚的延长释放版，到干眼症治疗药物丽眼达。

GlaxoSmithKline confirmed it raised the prices on 36 drugs, although none exceeded 3 percent.

葛兰素史克公司证实，他们提高了36种药物的价格，但是没有一种超过3%。

Drug pricing remains a hot topic for Democrats when they take control of the House this week.

药品价格对于本周控制众议院的民主党来说，仍然是一个热门话题。